akso health group - AHG

AHG

Close Chg Chg %
0.85 -0.03 -3.30%

Closed Market

0.82

-0.03 (3.30%)

Volume: 22.21K

Last Updated:

Sep 8, 2026, 3:57 PM EDT

Company Overview: akso health group - AHG

AHG Key Data

Open

$0.84

Day Range

0.80 - 0.90

52 Week Range

0.80 - 2.50

Market Cap

$725.94M

Shares Outstanding

854.04M

Public Float

N/A

Beta

-1.08

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.49

Yield

0.00%

Dividend

$0.38

EX-DIVIDEND DATE

Aug 1, 2018

SHORT INTEREST

N/A

AVERAGE VOLUME

18.36K

 

AHG Performance

1 Week
 
0.00%
 
1 Month
 
-37.19%
 
3 Months
 
-36.72%
 
1 Year
 
-55.64%
 
5 Years
 
-49.82%
 

AHG Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About akso health group - AHG

Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Qingdao, China.

AHG At a Glance

Akso Health Group
Qiantongyuan Building
Qingdao, Shandong 266000
Phone 86-152-1005-4919 Revenue 13.88M
Industry Internet Retail Net Income -18,737,077.31
Sector Retail Trade Employees 12
Fiscal Year-end 03 / 2027
View SEC Filings

AHG Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 118.712
Price to Book Ratio 10.796
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1,009.678
Enterprise Value to Sales 118.87
Total Debt to Enterprise Value 0.001

AHG Efficiency

Revenue/Employee 1,156,700.175
Income Per Employee -1,561,423.109
Receivables Turnover 10.835
Total Asset Turnover 0.062

AHG Liquidity

Current Ratio 21.766
Quick Ratio 21.743
Cash Ratio 0.02

AHG Profitability

Gross Margin -17.228
Operating Margin -28.919
Pretax Margin -149.686
Net Margin -134.989
Return on Assets -8.35
Return on Equity -9.86
Return on Total Capital -10.221
Return on Invested Capital -9.859

AHG Capital Structure

Total Debt to Total Equity 1.313
Total Debt to Total Capital 1.296
Total Debt to Total Assets 1.221
Long-Term Debt to Equity 0.001
Long-Term Debt to Total Capital 0.001
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Akso Health Group - AHG

Collapse All in section
All values USD millions. 2023 2024 2025 2026 5-year trend
Sales/Revenue
13.13M 2.41M 14.80M 13.88M
Sales Growth
+107.62% -81.65% +513.93% -6.18%
Cost of Goods Sold (COGS) incl D&A
11.87M 2.29M 15.08M 16.27M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - 2.15M 2.38M
-
Depreciation
- - 1.62K 6.77K
-
Amortization of Intangibles
- - 2.15M 2.37M
-
COGS Growth
+119.50% -80.72% +558.96% +7.92%
Gross Income
1.26M 121.91K (281.86K) (2.39M)
Gross Income Growth
+37.68% -90.36% -331.20% -748.40%
Gross Profit Margin
+9.63% +5.06% -1.91% -17.23%
2023 2024 2025 2026 5-year trend
SG&A Expense
15.48M 8.74M 3.65M 1.62M
Research & Development
- - - -
-
Other SG&A
15.48M 8.74M 3.65M 1.62M
SGA Growth
-3.78% -43.51% -58.31% -55.49%
Other Operating Expense
- - - -
-
Unusual Expense
- - 162.57M 16.76M
-
EBIT after Unusual Expense
(14.22M) (8.62M) (166.50M) (20.77M)
Non Operating Income/Expense
1.20M (452.92K) 34.11K (4.13K)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -100.00%
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
(13.02M) (9.08M) (166.47M) (20.78M)
Pretax Income Growth
+22.31% +30.29% -1,734.30% +87.52%
Pretax Margin
-99.13% -376.57% -1,125.14% -149.69%
Income Tax
17.49K 24.94K (30.84M) (2.00M)
Income Tax - Current - Domestic
17.49K 24.94K 2.99K 1.80K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - (30.84M) (2.00M)
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(13.04M) (9.10M) (135.63M) (18.78M)
Minority Interest Expense
112.09K (57.69K) (492.35K) (44.73K)
Net Income
(13.15M) (9.04M) (135.14M) (18.74M)
Net Income Growth
+22.15% +31.23% -1,394.47% +86.13%
Net Margin Growth
-100.11% -375.22% -913.38% -134.99%
Extraordinaries & Discontinued Operations
- - 11.79M (3.88K)
-
Discontinued Operations
- - 11.79M (3.88K)
-
Net Income After Extraordinaries
(1.36M) (9.05M) (135.14M) (18.74M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(1.36M) (9.05M) (135.14M) (18.74M)
EPS (Basic)
-0.0592 -0.1918 -0.474 -0.0259
EPS (Basic) Growth
+93.04% -223.99% -147.13% +94.54%
Basic Shares Outstanding
22.87M 47.17M 285.10M 722.71M
EPS (Diluted)
-0.0592 -0.1918 -0.474 -0.0259
EPS (Diluted) Growth
+93.04% -223.99% -147.13% +94.54%
Diluted Shares Outstanding
22.87M 47.17M 285.10M 722.71M
EBITDA
(14.22M) (8.62M) (1.78M) (1.63M)
EBITDA Growth
+6.17% +39.34% +79.41% +7.95%
EBITDA Margin
-108.23% -357.78% -12.00% -11.77%

Akso Health Group in the News